Bio Planet S.A. (WSE:BIP)
33.90
+1.50 (4.63%)
Jun 23, 2026, 4:41 PM CET
Bio Planet Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 321.15 | 310.96 | 279.48 | 254.55 | 201.47 | 205.45 |
Other Revenue | 0 | 0 | 0 | - | - | - |
| 321.15 | 310.96 | 279.48 | 254.55 | 201.47 | 205.45 | |
Revenue Growth (YoY) | 13.04% | 11.26% | 9.80% | 26.35% | -1.94% | 0.74% |
Cost of Revenue | 225.67 | 219.03 | 198.66 | 184.07 | 147.09 | 150.09 |
Gross Profit | 95.48 | 91.93 | 80.82 | 70.48 | 54.38 | 55.36 |
Selling, General & Admin | 77.64 | 75.8 | 71.61 | 62.74 | 48.37 | 46.65 |
Other Operating Expenses | 4.57 | 3.57 | 1.75 | 3.16 | 1.94 | 2.08 |
Operating Expenses | 85.28 | 82.48 | 76.34 | 68.81 | 51.74 | 50.18 |
Operating Income | 10.21 | 9.45 | 4.49 | 1.67 | 2.64 | 5.19 |
Interest Expense | -1.72 | -1.78 | -2.3 | -2.15 | -1.58 | -0.56 |
Interest & Investment Income | - | - | - | - | - | 0 |
Other Non Operating Income (Expenses) | -0.45 | 0.16 | 0.27 | 1.78 | -0.15 | -0.1 |
EBT Excluding Unusual Items | 8.04 | 7.82 | 2.45 | 1.3 | 0.91 | 4.53 |
Gain (Loss) on Sale of Assets | 0.16 | 0.23 | 0.02 | 0.07 | 0.14 | 0.04 |
Asset Writedown | -0.28 | -0.32 | -0.25 | -0.13 | -0.14 | -0.03 |
Pretax Income | 7.93 | 7.74 | 2.22 | 1.24 | 0.91 | 4.54 |
Income Tax Expense | 1.51 | 1.46 | 0.22 | 0.29 | 0.33 | 0.93 |
Net Income | 6.42 | 6.28 | 2 | 0.95 | 0.58 | 3.61 |
Net Income to Common | 6.42 | 6.28 | 2 | 0.95 | 0.58 | 3.61 |
Net Income Growth | 104.76% | 214.00% | 111.64% | 62.65% | -83.91% | -27.67% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | - | - | - | - | 7.14% | - |
EPS (Basic) | 2.14 | 2.09 | 0.67 | 0.32 | 0.19 | 1.29 |
EPS (Diluted) | 2.13 | 2.09 | 0.67 | 0.32 | 0.19 | 1.29 |
EPS Growth | 104.28% | 214.00% | 111.64% | 62.65% | -84.98% | -27.67% |
Free Cash Flow | -1.72 | -0.74 | 4.2 | 4.13 | -11.4 | -0.49 |
Free Cash Flow Per Share | -0.57 | -0.25 | 1.40 | 1.38 | -3.80 | -0.18 |
Dividend Per Share | 0.630 | 0.630 | 0.100 | - | - | 0.360 |
Dividend Growth | 530.00% | 530.00% | - | - | - | -52.00% |
Gross Margin | 29.73% | 29.56% | 28.92% | 27.69% | 26.99% | 26.95% |
Operating Margin | 3.18% | 3.04% | 1.60% | 0.66% | 1.31% | 2.52% |
Profit Margin | 2.00% | 2.02% | 0.72% | 0.37% | 0.29% | 1.76% |
Free Cash Flow Margin | -0.54% | -0.24% | 1.50% | 1.62% | -5.66% | -0.24% |
EBITDA | 13.27 | 12.56 | 7.46 | 4.59 | 4.07 | 6.64 |
EBITDA Margin | 4.13% | 4.04% | 2.67% | 1.80% | 2.02% | 3.23% |
D&A For EBITDA | 3.07 | 3.11 | 2.98 | 2.92 | 1.44 | 1.45 |
EBIT | 10.21 | 9.45 | 4.49 | 1.67 | 2.64 | 5.19 |
EBIT Margin | 3.18% | 3.04% | 1.60% | 0.66% | 1.31% | 2.52% |
Effective Tax Rate | 19.06% | 18.84% | 9.95% | 23.48% | 36.15% | 20.40% |
Revenue as Reported | 321.2 | 311.01 | 279.48 | 254.63 | 201.46 | 205.48 |